Novel hybrid polymer nanocarriers enable effective vaccine delivery in the lungs and the targeted activation of immune cells.

Published, peer-reviewed research shows a patent-pending, virus-mimicking platform technology developed at Purdue University ...

The Proceedings of the National Academy of Sciences has published research about a Purdue University virus-mimicking platform ...

Published, peer-reviewed research shows a patent-pending, virus-mimicking platform technology developed at Purdue University ...

Scientists can peer into cells to get a limited view of their activity using microscopes and other tools. However, cells and ...

A new cancer therapy wakes up immune cells inside tumors and turns them against cancer.

Yesterday we explored four key myths and why they don’t stand up to scrutiny: ‘Vaccines were never properly tested’ ...

The #1 Rule Experts Say to Follow When You Forget Wet Clothes in the Washer Tesla dealership arsonist learns prison sentence ...

In my short stint as a resident doctor in oncology, the overwhelming impression was one of complex and expensive treatments doing little for patient survival or quality of life. The options available ...

Researchers at Ludwig Maximilian University of Munich developed hybrid PLGA-PBAE nanoparticles that delivered mRNA vaccines ...

Researchers from Carnegie Mellon University have discovered a way to target RNA that could lead to new treatment options for myotonic dystrophy type 1 (DM1), the most common adult-onset form of ...